Last updated: 17 June 2024 at 8:18pm EST

Darren Cline Net Worth




The estimated Net Worth of Darren S Cline is at least 4.2 百万$ dollars as of 28 May 2020. Mr. Cline owns over 7,356 units of GW Pharmaceuticals stock worth over 515$ and over the last 10 years he sold GWPH stock worth over 4,199,687$. In addition, he makes 0$ as Chief Commercial Officer - U.S. at GW Pharmaceuticals.

Mr. Cline GWPH stock SEC Form 4 insiders trading

Darren has made over 25 trades of the GW Pharmaceuticals stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 7,356 units of GWPH stock worth 515$ on 28 May 2020.

The largest trade he's ever made was exercising 12,761 units of GW Pharmaceuticals stock on 13 December 2016 worth over 312,006$. On average, Darren trades about 3,154 units every 44 days since 2015. As of 28 May 2020 he still owns at least 7,356 units of GW Pharmaceuticals stock.

You can see the complete history of Mr. Cline stock trades at the bottom of the page.





Darren Cline biography

Darren Cline serves as Chief Commercial Officer - U.S. of the Company. Darren Cline is an accomplished biopharmaceutical executive with over 25 years of commercial experience, including hematology and oncology, orphan and ultra- orphan arenas. Mr. Cline is Executive Vice President, Commercial at Seattle Genetics, Inc., where he oversees all marketing, sales, and managed markets. He was directly involved in the commercial build out for the launch of Adcetris, an antibody-based biologic the US Food and Drug Administration approved for treatment of certain hematologic cancers; he played an integral role driving Adcetris’ continued growth to over $300 million in revenue. Prior to Seattle Genetics, Mr. Cline was at Alexion Pharmaceuticals, where he was part of the initial commercial leadership team for the Soliris launch, helping to build out key sales functions that were instrumental in Soliris becoming a billion-dollar brand. Mr. Cline received his undergraduate degree from San Diego State University and his MBA from Pepperdine University. Mr. Cline is also currently a non-executive director of Stemline Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics.



How old is Darren Cline?

Darren Cline is 55, he's been the Chief Commercial Officer - U.S. of GW Pharmaceuticals since 2019. There are 7 older and 5 younger executives at GW Pharmaceuticals. The oldest executive at GW Pharmaceuticals is William Waldegrave, 73, who is the Non-Executive Independent Director.

What's Darren Cline's mailing address?

Darren's mailing address filed with the SEC is C/O PLIANT THERAPEUTICS, INC., 260 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at GW Pharmaceuticals

Over the last 6 years, insiders at GW Pharmaceuticals have traded over 60,899,192$ worth of GW Pharmaceuticals stock and bought 7,200 units worth 48,960$ . The most active insiders traders include Geoffrey W Dr GuyJames NobleJustin D. Gover. On average, GW Pharmaceuticals executives and independent directors trade stock every 10 days with the average trade being worth of 8,011$. The most recent stock trade was executed by Douglas B. Snyder on 6 April 2021, trading 8,400 units of GWPH stock currently worth 152,208$.



What does GW Pharmaceuticals do?



What does GW Pharmaceuticals's logo look like?

GW Pharmaceuticals logo

Complete history of Mr. Cline stock trades at GW Pharmaceuticals、Seagen Inc、Stemline Therapeutics、Pliant Therapeutics

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
28 May 2020 Darren S Cline
U.S. Chief Commercial Officer
オプション行使 7,356 125.46$ 922,884$
28 May 2020
7,356
29 Nov 2018 Darren S Cline
SVP、Commercial
販売 7,000 62.88$ 440,160$
29 Nov 2018
72,556
21 Nov 2018 Darren S Cline
SVP、Commercial
販売 4,167 56.68$ 236,186$
21 Nov 2018
79,556
27 Aug 2018 Darren S Cline
SVP、Commercial
販売 4,784 74.23$ 355,116$
27 Aug 2018
65,079
12 Jun 2018 Darren S Cline
SVP、Commercial
販売 12,054 69.00$ 831,726$
12 Jun 2018
69,863
9 May 2018 Darren S Cline
SVP、Commercial
オプション行使 9,000 16.20$ 145,800$
9 May 2018
80,831
3 May 2018 Darren S Cline
SVP、Commercial
販売 4,000 53.81$ 215,240$
3 May 2018
71,831
6 Sep 2017 Darren S Cline
SVP、Commercial
オプション行使 10,048 15.94$ 160,165$
6 Sep 2017
82,254
31 Aug 2017 Darren S Cline
SVP、Commercial
販売 7,569 52.51$ 397,448$
31 Aug 2017
72,206
28 Aug 2017 Darren S Cline
SVP、Commercial
販売 1,788 47.89$ 85,627$
28 Aug 2017
76,868
7 Aug 2017 Darren S Cline
SVP、Commercial
オプション行使 6,000 18.46$ 110,760$
7 Aug 2017
67,656
16 Dec 2016 Darren S Cline
SVP、Commercial
オプション行使 3,100 16.41$ 50,871$
16 Dec 2016
61,604
13 Dec 2016 Darren S Cline
SVP、Commercial
オプション行使 12,761 24.45$ 312,006$
13 Dec 2016
59,698
9 Sep 2016 Darren S Cline
SVP、Commercial
オプション行使 4,167 15.46$ 64,422$
9 Sep 2016
55,743
9 Sep 2016 Darren S Cline
SVP、Commercial
オプション行使 4,167 15.46$ 64,422$
9 Sep 2016
55,743
6 Sep 2016 Darren S Cline
SVP、Commercial
販売 5,397 46.01$ 248,316$
6 Sep 2016
51,576
6 Sep 2016 Darren S Cline
SVP、Commercial
販売 5,397 46.01$ 248,316$
6 Sep 2016
51,576
22 Aug 2016 Darren S Cline
SVP、Commercial
販売 1,774 46.59$ 82,651$
22 Aug 2016
40,973
22 Aug 2016 Darren S Cline
SVP、Commercial
販売 1,774 46.59$ 82,651$
22 Aug 2016
40,973
2 Jun 2016 Darren S Cline
SVP、Commercial
販売 3,366 42.07$ 141,608$
2 Jun 2016
42,747
11 Nov 2015 Darren S Cline
SVP、Commercial
販売 5,769 45.68$ 263,528$
11 Nov 2015
37,713
20 Aug 2015 Darren S Cline
SVP、Commercial
販売 2,231 42.02$ 93,747$
20 Aug 2015
31,482
20 Aug 2015 Darren S Cline
SVP、Commercial
販売 2,231 42.02$ 93,747$
20 Aug 2015
31,482
20 Aug 2015 Darren S Cline
SVP、Commercial
販売 2,231 42.02$ 93,747$
20 Aug 2015
31,482
13 Mar 2015 Darren S Cline
SVP、Commercial
販売 7,500 38.65$ 289,875$
13 Mar 2015
33,135


GW Pharmaceuticals executives and stock owners

GW Pharmaceuticals executives and other stock owners filed with the SEC include: